Teladoc Health Q1 2026 Revenue Falls 2% to $613.8M, Net Loss Narrows to $63.8M

Teladoc Health, Inc.

2026-Q1 EPS reported -$0.36 revenue$613,845,000

First Quarter 2026 revenue of $613.8 million, down 2% year-over-year
Net loss improved to $63.8 million ($0.36 per share) from $93.0 million ($0.53 per share) in prior year
Adjusted EBITDA was $58.2 million, essentially flat year-over-year
Integrated Care segment revenue up 2% to $395.4 million; BetterHelp down 9% to $218.4 million
Company reaffirmed full-year 2026 outlook with revenue range $2.481B-$2.576B and adjusted EBITDA $267M-$306M

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Teladoc Health, Inc. reported the three months ended March 31, 2026 ("First Quarter 2026") results: revenue $613.8 million, net income $63.8 million, or $0.36 per share, EPS $0.36 per share. Guidance reaffirmed.

Period: the three months ended March 31, 2026 ("First Quarter 2026")
Revenue: $613.8 million
Net income: $63.8 million, or $0.36 per share
EPS: $0.36 per share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

First Quarter 2026 revenue of $613.8 million, down 2% year-over-year • First Quarter 2026 net loss of $63.8 million, or $0.36 per share

View on SEC.gov

1436 earnings releases filed in the last 30 days. Browse all earnings releases →

Teladoc Health, Inc. filing history →

Source: SEC EDGAR

accession 0001477449-26-000026

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.